Skip to main content

Table 1 Baseline demographic characteristics of enrolled patients

From: Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial

 

LAM 7

LAM 10

Included in ITT analysis (n)

75

75

Age (mean ± SD)

50 ± 13

53 ± 13

Male/female (n)

35/40

37/38 p = 0.869

Smokers (n)

25

23 p = 0.8602

  1. ITT intention-to-treat; SD standard deviation; LAM 7 lansoprazole + amoxicillin + moxifloxacin for 7 days; LAM 10: lansoprazole + amoxicillin + moxifloxacin for 10 days.